TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21584922

Group type: EXPERIMENTAL
Intervention: Intensive subcutaneous insulin protocol
Number of subjects: 65

Group type: COMPARATOR
Intervention: Standard care with sliding scale insulin
Number of subjects: 65
Study: 20215786

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with etoposide, Adriamycin and cisplatin (EAP)
Number of subjects: 309

Group type: COMPARATOR
Intervention: Supportive care (control group)
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with EAP
Number of subjects: 309
Study: 17469888

Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 387

Group type: COMPARATOR
Intervention: Standard treatment as usual
Number of subjects: 387
Study: 15960083

Group type: EXPERIMENTAL
Intervention: Tactile signals administered to the treatment group to indicate the arrival and location of interrupting tasks.
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control participants had to remember to visually check for the interrupting tasks.
Number of subjects: 61
Study: 12360175

Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg daily)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Fenofibrate (200 mg daily)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both atorvastatin and fenofibrate
Number of subjects: 29
Study: 10432959

Group type: EXPERIMENTAL
Intervention: Etidronate 400 mg per day for 14 days followed by 500 mg calcium carbonate per day for 76 days, repeated for one year
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 7672148

Group type: EXPERIMENTAL
Intervention: Intracytoplasmic sperm injection (ICSI)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Subzonal insemination (SUZI)
Number of subjects: 96
Study: 2341204

Group type: EXPERIMENTAL
Intervention: Expectancy instructional condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonexpectancy instructional condition
Number of subjects: 0
Study: 6936978

Group type: COMPARATOR
Intervention: 3 injections of a tyrosine adsorbed grass pollen vaccine (Pollagen) immediately preseasonal
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 5 injections of a tyrosine adsorbed grass pollen vaccine (Pollagen)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 18 injections of a 7 grass pollen extract (semi‐depot, Allpyral)
Number of subjects: 70

Group type: COMPARATOR
Intervention: 3 injections of a tyrosine adsorbed grass pollen vaccine (Pollagen)
Number of subjects: 70
Study: 31430749

Group type: EXPERIMENTAL
Intervention: Cervical or segmental dystonia diagnosis
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Unusual form of thumb flexion dystonia
Number of subjects: 227
Study: 28624819

Group type: EXPERIMENTAL
Intervention: Intravenous cefazolin 2 g
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intravenous saline (control group)
Number of subjects: 100
Study: 25657052

Group type: EXPERIMENTAL
Intervention: Active Classrooms intervention (8-week classroom-based intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Teachers' perceptions of the intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Students' enjoyment of the programme
Number of subjects: 0
Study: 24680234

Group type: EXPERIMENTAL
Intervention: Brief, 5-session, problem-focused couple therapy for depression
Number of subjects: 35
Study: 23015558

Group type: EXPERIMENTAL
Intervention: ASR femoral component
Number of subjects: 19
Study: 19679248

Group type: EXPERIMENTAL
Intervention: Atenolol-based therapy
Number of subjects: 2073

Group type: COMPARATOR
Intervention: Amlodipine-based therapy
Number of subjects: 2073

Group type: EXPERIMENTAL
Intervention: Beta-blocker therapy
Number of subjects: 2073

Group type: EXPERIMENTAL
Intervention: Overall analysis of heart rate (HR)
Number of subjects: 2073
Study: 17236918

Group type: EXPERIMENTAL
Intervention: Intravenous prophylactic antibiotics (penicillin or clindamycin for penicillin-allergic subjects)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Saline placebo (0.9% saline)
Number of subjects: 118
Study: 15051598

Group type: EXPERIMENTAL
Intervention: 70 g MCTs (66% 8:0 and 34% 10:0)
Number of subjects: 17

Group type: COMPARATOR
Intervention: high-oleic sunflower oil (89.4% 18:1)
Number of subjects: 17
Study: 12200551

Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation
Number of subjects: 500

Group type: COMPARATOR
Intervention: Synchronized intermittent mandatory ventilation
Number of subjects: 500
Study: 10535880

Group type: EXPERIMENTAL
Intervention: Interferon (3 MU 3 times weekly) for 24 months
Number of subjects: 53

Group type: COMPARATOR
Intervention: Discontinuation of interferon
Number of subjects: 53
Study: 7594123

Group type: EXPERIMENTAL
Intervention: Cholesterol-lowering diets (30%, 26%, 22%, and 18% of energy from fat; 300, 200, 100, and 100 mg cholesterol)
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Cholesterol-lowering diets
Number of subjects: 365
Study: 2215560

Group type: EXPERIMENTAL
Intervention: Monitoring of hemoglobin A1c levels (n = 115)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (n = 107)
Number of subjects: 240
Study: 361162

Group type: EXPERIMENTAL
Intervention: Iron treatment
Number of subjects: 137

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study: 31816598

Group type: EXPERIMENTAL
Intervention: Control plus exercise
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sleep restriction (SR)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Sleep restriction plus exercise
Number of subjects: 19
Study: 29334292

Group type: EXPERIMENTAL
Intervention: Fascial therapy (3 sessions, 60 min each)
Number of subjects: 16
Study: 27194235

Group type: EXPERIMENTAL
Intervention: Colonic irrigation using the Ashong colonic irrigation apparatus (ACIA), performed twice daily for 6 consecutive days per week for 1-4 weeks.
Number of subjects: 18
Study: 25449510

Group type: EXPERIMENTAL
Intervention: Apical pacing
Number of subjects: 188

Group type: COMPARATOR
Intervention: Septal pacing
Number of subjects: 188
Study: 22116114

Group type: EXPERIMENTAL
Intervention: Conservative therapy
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Higher class pain medication
Number of subjects: 95
Study: 20205646

Group type: EXPERIMENTAL
Intervention: Non-steroidal anti-inflammatory drugs (NSAIDs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cyclooxygenase-2 inhibitors
Number of subjects: 0
Study: 17646669

Group type: EXPERIMENTAL
Intervention: 1 year trastuzumab
Number of subjects: 3386

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 3386
Study: 15647216

Group type: EXPERIMENTAL
Intervention: Lung volume reduction surgery (LVRS)
Number of subjects: 0
Study: 12173840

Group type: EXPERIMENTAL
Intervention: Cold crystalloid cardioplegia (CCC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cold blood cardioplegia (CBC)
Number of subjects: 40
Study: 10461288

Group type: EXPERIMENTAL
Intervention: Single lead unipolar system (RV-CAN)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Single lead unipolar system with additional IVC lead (RV-CAN + IVC)
Number of subjects: 17
Study: 7606425

Group type: EXPERIMENTAL
Intervention: New formulation (IDEOS) containing 500 mg calcium and 400 IU vitamin D3, taken as one tablet twice daily for six months
Number of subjects: 91

Group type: COMPARATOR
Intervention: Separate administration of 8 drops of vitamin D3 (800 IU/day) and one calcium carbonate 500 mg tablet twice daily for six months
Number of subjects: 91
Study: 2120785

Group type: EXPERIMENTAL
Intervention: Partial ileal bypass (PIB), n = 58
Number of subjects: 110

Group type: COMPARATOR
Intervention: Dietary control, n = 52
Number of subjects: 110
Study: 91886

Group type: EXPERIMENTAL
Intervention: Intramuscular iodised oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo saline
Number of subjects: 0
Study: 30985694

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral rectus sheath block (RSB) using 40 mL of 0.375% ropivacaine
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group receiving RSB using 40 mL of normal saline
Number of subjects: 46
Study: 28333021

Group type: EXPERIMENTAL
Intervention: Paclitaxel + Trastuzumab (group 1)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Paclitaxel alone (group 2)
Number of subjects: 68
Study: 26036453

Group type: EXPERIMENTAL
Intervention: SIgA response to performance or interpersonal stressors
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: SIgA
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Changes in SIgA over time
Number of subjects: 82

Group type: COMPARATOR
Intervention: Cortisol and sAA
Number of subjects: 82
Study: 24112545

Group type: EXPERIMENTAL
Intervention: Whole brain helical Tomotherapy with integrated boost (30 Gy in 10 fractions, 50 Gy boost to brain metastases, hippocampal-sparing)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional whole brain radiotherapy (30 Gy in 10 fractions)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Whole brain helical Tomotherapy with integrated boost
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional whole brain radiotherapy
Number of subjects: 0
Study: 21377899

Group type: EXPERIMENTAL
Intervention: Mindful learning condition
Number of subjects: 32

Group type: COMPARATOR
Intervention: Mindless learning condition
Number of subjects: 32
Study: 19920749

Group type: EXPERIMENTAL
Intervention: True acupuncture
Number of subjects: 9

Group type: COMPARATOR
Intervention: Sham acupuncture (placebo control)
Number of subjects: 9
Study: 16487501

Group type: EXPERIMENTAL
Intervention: PCIA using morphine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: PCIA using tramadol
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: PCIA using tramadol with lornoxicam
Number of subjects: 45
Study: 12620951

Group type: EXPERIMENTAL
Intervention: Remifentanil (1 micro g x kg(‐1) iv followed by a continuous infusion of 0.2 to 0.5 micro g x kg(‐1) x min(‐1))
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nitroprusside (0.25 micro g x kg(‐1) x min(‐1) iv and alfentanil iv)
Number of subjects: 40
Study: 11189097

Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 18882

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18882
Study: 9345173

Group type: EXPERIMENTAL
Intervention: Daily supplementation with high energy groundnut biscuits (4.3 MJ/day) for about 20 weeks before delivery
Number of subjects: 2047

Group type: COMPARATOR
Intervention: Control group (after delivery)
Number of subjects: 2047
Study: 8155388

Group type: EXPERIMENTAL
Intervention: Toremifene 60 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Toremifene 300 mg
Number of subjects: 30
Study: 3279769

Group type: EXPERIMENTAL
Intervention: Calcitriol (0.8 micrograms per day)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 29497963

Group type: EXPERIMENTAL
Intervention: High Intensity (HI) exercise
Number of subjects: 277

Group type: COMPARATOR
Intervention: Low-to-moderate Intensity (LMI) exercise
Number of subjects: 277
Study: 24997863

Group type: EXPERIMENTAL
Intervention: Rg3-enriched Korean red ginseng (400 mg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Wheat bran (400 mg)
Number of subjects: 23
Study: 22081263

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (DA) 500 mcg every 3 weeks (Q3 W) or 2.25 mcg/kg DA weekly (QW) for 15 weeks
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (DA)
Number of subjects: 705
Study: 19929694

Group type: EXPERIMENTAL
Intervention: DNA/DNA regimen
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: DNA/Ad5 regimen
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Ad5/Ad5 regimen
Number of subjects: 307

Group type: COMPARATOR
Intervention: Ad5 vaccine alone
Number of subjects: 307
Study: 19025505

Group type: EXPERIMENTAL
Intervention: Physiotherapist-directed program of advice and exercises
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no physiotherapy intervention)
Number of subjects: 56
Study: 16188181

Group type: EXPERIMENTAL
Intervention: KTP 532 nm laser treatment
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control side (no treatment)
Number of subjects: 26
Study: 12535050

Group type: EXPERIMENTAL
Intervention: Dissolvable collagen punctal plugs (lower puncta occluded)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Dissolvable collagen punctal plugs (both upper and lower puncta occluded)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Age- and gender-matched normals (control group)
Number of subjects: 62
Study: 12359987

Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 1026

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 1026

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 1026

Group type: EXPERIMENTAL
Intervention: Combined medication (Nitrendipine, Atenolol, Captopril)
Number of subjects: 1026
Study: 8617693

Group type: EXPERIMENTAL
Intervention: Light box (N=9)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Head-mounted unit (HMU) (N=12)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo light box (N=12)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo HMU (N=10)
Number of subjects: 43
Study: 2024567

Group type: EXPERIMENTAL
Intervention: mepivacaine 2% + adrenaline 1:200,000 (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: mepivacaine 2% (n = 20)
Number of subjects: 40
Study: 7259925

Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg/day
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cimetidine 1600 mg/day
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cimetidine withdrawal
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cimetidine pharmacokinetics
Number of subjects: 19
Study: 31297681

Group type: EXPERIMENTAL
Intervention: Incentive participants earned up to $10 per day for 2 years for providing blood samples that showed either reduced or undetectable viral loads.
Number of subjects: 102

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 102
Study: 28729305

Group type: EXPERIMENTAL
Intervention: Cunningham biomechanical reposition technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modified Milch biomechanical reposition technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Scapular manipulation biomechanical reposition technique
Number of subjects: 0
Study: 26500019

Group type: EXPERIMENTAL
Intervention: web-based CBT (3 F2F sessions and up to 8 web-based modules over 6 months)
Number of subjects: 132

Group type: COMPARATOR
Intervention: care as usual (waiting list for regular F2F CBT for 6 months)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: web-based CBT
Number of subjects: 132
Study: 22999319

Group type: EXPERIMENTAL
Intervention: Functional‐rTMS (EMG‐triggered rTMS)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Passive‐rTMS (rTMS only; control)
Number of subjects: 18
Study: 21239090

Group type: EXPERIMENTAL
Intervention: High Protein (HP) diet (3.0 g protein/kg BW) for 3 weeks
Number of subjects: 23

Group type: COMPARATOR
Intervention: Usual Protein (UP) diet (1.5 g protein/kg BW) for 3 weeks
Number of subjects: 23
Study: 19994682

Group type: EXPERIMENTAL
Intervention: Gaining in wisdom and activating channels group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: JIN's 3‐needling group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine acupuncture group
Number of subjects: 60
Study: 17823422

Group type: EXPERIMENTAL
Intervention: High vitamin E diet
Number of subjects: 251
Study: 15330150

Group type: EXPERIMENTAL
Intervention: steroids and oral magnesium
Number of subjects: 28

Group type: COMPARATOR
Intervention: steroids and placebo
Number of subjects: 28
Study: 11548916

Group type: EXPERIMENTAL
Intervention: Strength-trained group (80% 1RM - average training velocity = .308 m/s)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Power-trained group (60% 1RM - average training velocity = .398 m/s)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21
Study: 9628402

Group type: EXPERIMENTAL
Intervention: Rapid aiming movements with peripheral and/or central feedback information
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control of aiming movements with feedback information
Number of subjects: 0
Study: 7740465

Group type: EXPERIMENTAL
Intervention: 30 micrograms ethinyloestradiol combination
Number of subjects: 2

Group type: COMPARATOR
Intervention: 20 micrograms ethinyloestradiol combination
Number of subjects: 2

Group type: COMPARATOR
Intervention: Comparison between 30 micrograms and 20 micrograms ethinyloestradiol combinations
Number of subjects: 2
Study: 2965633

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (ANP)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Angiotensin II (ANG II)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: ANP with background infusion of ANG II
Number of subjects: 8
Study: 31859677

Group type: EXPERIMENTAL
Intervention: Mobile phone‐based physical activity education (mPED) intervention
Number of subjects: 203

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 203
Study: 29178700

Group type: EXPERIMENTAL
Intervention: Group A: Manual curettes, sonic-driven scaler, and prophylaxis brush
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Group B: Manual curettes, air polishing with glycine powder, and prophylaxis brush
Number of subjects: 105

Group type: COMPARATOR
Intervention: Group C: Manual curettes, sonic-driven scaler, and prophylaxis brush with chlorhexidine varnish
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Group D: Manual curettes, air polishing with glycine powder, and prophylaxis brush with chlorhexidine varnish
Number of subjects: 105
Study: 24131567

Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure Therapy (VRE)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Exposure Group Therapy (EGT)
Number of subjects: 63
Study: 23235922

Group type: EXPERIMENTAL
Intervention: Fasting for 60 hours
Number of subjects: 10
Study: 21729424

Group type: EXPERIMENTAL
Intervention: Group B (symptom) - read vignettes describing symptoms of dementia
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Group C (label) - read vignettes with a diagnostic label of dementia
Number of subjects: 494

Group type: COMPARATOR
Intervention: Group A (control) - responded to stigma questions directly
Number of subjects: 494
Study: 17625032

Group type: EXPERIMENTAL
Intervention: 5 mW laser irradiation (650 nm), applied transmeatally for 15 minutes, once daily for a week
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo laser
Number of subjects: 45
Study: 17069104

Group type: EXPERIMENTAL
Intervention: Respiratory specialists (RS)
Number of subjects: 472

Group type: COMPARATOR
Intervention: Primary care physicians
Number of subjects: 472
Study: 14508737

Group type: EXPERIMENTAL
Intervention: Molloplast‐B
Number of subjects: 20

Group type: COMPARATOR
Intervention: MPDS‐SL
Number of subjects: 20
Study: 10627439

Group type: EXPERIMENTAL
Intervention: Syndecan-1 elevated in patients (median, 643 units/mL)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Syndecan-1 as a continuous variable in multivariate Cox regression model
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Syndecan-1 dichotomized by best cutoff (66th percentile, 1170 units/mL)
Number of subjects: 174
Study: 9358622

Group type: EXPERIMENTAL
Intervention: ELISA-PCR method for HPA-1 genotyping
Number of subjects: 100
Study: 1302384

Group type: EXPERIMENTAL
Intervention: Passive drain
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Closed suction drain
Number of subjects: 150

Group type: COMPARATOR
Intervention: No drain
Number of subjects: 150
Study: 2931937

Group type: EXPERIMENTAL
Intervention: Endoscopic injection sclerotherapy (ST)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Conservative therapy (balloon tamponade and/or vasopression infusion)
Number of subjects: 107
Study: 29678977

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (sleep-inducing dose)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 370
Study: 26915831

Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide 3% and clindamycin 1% (BPO + CLN)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Azelaic acid 20% (AzA)
Number of subjects: 215
Study: 24574278

Group type: EXPERIMENTAL
Intervention: Xylometazoline
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Xylitol (Xlear Nasal Spray®)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Physiological saline
Number of subjects: 42
Study: 22190336

Group type: EXPERIMENTAL
Intervention: Extended theory of planned behavior (TPB) intervention for 4 weeks
Number of subjects: 183

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 183
Study: 20008025

Group type: EXPERIMENTAL
Intervention: Tobacco use intervention (specific details not provided)
Number of subjects: 11642
Study: 17396687

Group type: EXPERIMENTAL
Intervention: Standard PRP (19 eyes)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Selective PRP (20 eyes)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: PDT (17 eyes)
Number of subjects: 57

Group type: COMPARATOR
Intervention: All groups (PRP, selective PRP, PDT)
Number of subjects: 57
Study: 15867701

Group type: EXPERIMENTAL
Intervention: High-Cushion Kodel Heel Protector (bunny boot)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Egg Crate Heel Lift Positioner (egg crate)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: EHOB Foot Waffle Air Cushion (foot waffle)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 240
Study: 12185402

Group type: EXPERIMENTAL
Intervention: Hydrocortisone 20 mg administered twice daily for 7 days
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: TRH administration after L-tryptophan infusion
Number of subjects: 14
Study: 9698728

Group type: EXPERIMENTAL
Intervention: One layer flap (myocutaneous, MC)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Two layers' dieresis (interfascial, IF)
Number of subjects: 68
Study: 8527275

Group type: EXPERIMENTAL
Intervention: Rifampicin 600 mg p.o. daily for 2 weeks
Number of subjects: 9

Group type: COMPARATOR
Intervention: Quinine alone (no pretreatment)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Isoniazid 300 mg p.o. daily for 1 week
Number of subjects: 9